Related Experiment Video
Updated: Aug 8, 2026

Visualizing Leukocyte Rolling and Adhesion in Angiotensin II-Infused Mice: Techniques and Pitfalls
Published on: January 4, 2018
[Endothelial dysfunction and vasculitis: a close relationship]
M López Rodríguez1, J Gómez Cerezo, F J Barbado Hernández
1Servicio de Medicina Interna, Hospital Universitario La Paz, Madrid, España. monlr2001@hotmail.com
Insights
Endothelial dysfunction (ECD) contributes to vasculitis and collagen diseases, accelerating atherosclerosis. Emerging treatments targeting systemic inflammation, like anti-TNF therapies, show promise for managing ECD in these conditions.
Area of Science:
- Cardiovascular Medicine
- Rheumatology
- Immunology
Context:
- Endothelial dysfunction (ECD) plays a crucial role in the development of various diseases, particularly collagen diseases and vasculitis.
- ECD precedes atherosclerotic coronary damage and thrombotic events, leading to accelerated atherogenesis.
- Mechanisms of ECD in vasculitis extend beyond local inflammation, involving systemic inflammatory mediators like C-reactive protein and tumor necrosis factor-alpha.
Purpose:
- To explore the role of endothelial dysfunction in the pathogenesis of collagen diseases and vasculitis.
- To investigate the mechanisms underlying ECD in vasculitis, including systemic inflammatory influences.
- To review preliminary findings on specific treatments for ECD in vasculitis, such as anti-TNF therapies.
Summary:
- Endothelial dysfunction (ECD) is a key factor in the development of collagen diseases and vasculitis.
- Systemic inflammatory mediators, including C-reactive protein and TNF-alpha, significantly contribute to ECD in vasculitis.
- Preliminary studies suggest that anti-TNF therapies may offer a specific treatment approach for ECD in vasculitis.
Impact:
- Highlights the critical role of endothelial dysfunction in vasculitis and related conditions.
- Underscores the importance of systemic inflammation in driving ECD.
- Suggests potential therapeutic avenues targeting endothelial function in vasculitis management.
Abstract:
Endothelial dysfunction (ECD) is implicated in the etiopathogenesis of several entities, with special interest and new perspectives in collagen diseases and vasculitis. ECD precedes development of atherosclerotic coronary damage and thrombotic events, with accelerated atherogenesis. Mechanisms of ECD that are involved in vasculitis are not simply due to focal vascular inflammation, since it may be caused by inflammatory systemic mediators, for example C reactive protein and tumor necrosis factor (TNF) alpha. We already have preliminary studies about specific ECD treatment in vasculitis, with drugs such as anti-TNF.
Related Concept Videos
Inflammation
Venous Thrombosis I: Introduction
Coronary Artery Disease II: Pathophysiology
Regulation of Angiogenesis and Blood Supply
Inflammatory Response I: Vascular and Cellular
Overview of the Vascular System

